503B Outsourcing Facilities Market Report 2026

503B Outsourcing Facilities Market Overview

• 503B Outsourcing Facilities market size has reached to $5.85 billion in 2025 • Expected to grow to $9.81 billion in 2030 at a compound annual growth rate (CAGR) of 10.9% • Growth Driver: Increasing Number Of Surgical Procedures Fueling The Growth Of The Market Due To Rising Demand For Compounded Sterile Preparations And Perioperative Medications • Market Trend: Expansion Of Ready-To-Administer Premix IV Solutions Strengthens Hospital Drug Supply Capabilities In 503B Outsourcing Facilities • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under 503B Outsourcing Facilities Market?

503B outsourcing facilities are specialized pharmaceutical compounding centers established under section 503B of the U.S. Federal Food, Drug, and Cosmetic Act. They produce large batches of sterile and non-sterile compounded medications for hospitals, clinics, and healthcare providers without requiring individual prescriptions. 503B outsourcing facilities must register with the U.S. Food and Drug Administration and comply with current good manufacturing practices (cGMP) to ensure quality and safety. The main service types of 503B outsourcing facilities include sterile compounding, non sterile compounding, quality testing, packaging, and other service types. Sterile compounding refers to the preparation of sterile medications under controlled conditions to ensure safety and compliance for patient use. These services are provided across therapeutic areas such as oncology, pain management, ophthalmology, infectious diseases, and other therapeutic areas and support dosage forms including injectables, oral formulations, topical formulations, and ophthalmic formulations. They are distributed through direct sales, wholesale distributors, and group purchasing organizations, and they are utilized by end users including hospitals, clinics, ambulatory surgical centers, long term care facilities, and others.

What Is The 503B Outsourcing Facilities Market Growth Forecast?

The 503B outsourcing facilities market size is expected to see rapid growth in the next few years. It will grow to $9.81 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to expansion of outpatient infusion and ambulatory care services, increased cost containment pressures across healthcare systems, enhanced regulatory compliance and inspection requirements, growth in sterility assurance and quality validation processes, consolidation of 503b outsourcing facilities and contract manufacturing providers. Major trends in the forecast period include increasing drug shortage driven outsourcing to 503b facilities, tightening fda cgmp compliance and inspection enforcement, growing demand for sterile injectable preparations in hospitals and clinics, expansion of hospital group purchasing organization (gpo) contracting with outsourcing facilities, shift from in-house hospital compounding to centralized outsourced pharmaceutical manufacturing.

Global 503B Outsourcing Facilities Market Segmentation

1) By Service Type: Sterile Compounding, Non Sterile Compounding, Quality Testing, Packaging, Other Service Types 2) By Therapeutic Area: Oncology, Pain Management, Ophthalmology, Infectious Diseases, Other Therapeutic Areas 3) By Dosage Form: Injectables, Oral Formulations, Topical Formulations, Ophthalmic Formulations 4) By Distribution Channel: Direct Sales, Wholesale Distributors, Group Purchasing Organizations 5) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Long Term Care Facilities, Other End Users Subsegments: 1) By Sterile Compounding: Injectable Preparations, Ophthalmic Solutions, Intravenous Admixtures, Prefilled Syringes, Anesthesia Medications 2) By Non Sterile Compounding: Topical Formulations, Oral Suspensions, Capsules And Tablets, Creams And Ointments, Suppositories 3) By Quality Testing: Sterility Testing, Endotoxin Testing, Potency Testing, Stability Testing, Microbial Testing 4) By Packaging: Unit Dose Packaging, Blister Packaging, Vial Packaging, Syringe Packaging, Tamper Evident Packaging 5) By Other Service Types: Formulation Development, Labeling Services, Storage And Distribution, Regulatory Support Services, Repackaging Services

What Is The Driver Of The 503B Outsourcing Facilities Market?

The increasing number of surgical procedures is expected to propel the growth of the 503B outsourcing facilities market going forward. Surgical procedures refer to medical operations performed by healthcare professionals to treat, diagnose, or manage diseases, injuries, or medical conditions through manual or instrumental techniques. The increasing number of surgical procedures is rising due to the growing prevalence of chronic and age-related diseases, which is driving higher demand for both elective and emergency surgical interventions worldwide. 503B outsourcing facilities support the surgical procedures by supplying compounded sterile preparations, including anesthetics, pain management drugs, and emergency medications, that help hospitals and surgical centers maintain a reliable supply of essential medications for perioperative care. For instance, in April 2025, according to the British Association of Aesthetic Plastic Surgeons, a UK-based professional organization, between 2023 and 2024, cosmetic surgical procedures increased by 5%, reaching a total volume of 27,462 procedures performed in 2024. Therefore, the increasing number of surgical procedures is driving the growth of the 503B outsourcing facilities industry.

Key Players In The Global 503B Outsourcing Facilities Market

Major companies operating in the 503b outsourcing facilities market are Nephron Pharmaceuticals Corporation, QuVa Pharma Inc., Central Admixture Pharmacy Services Inc. (CAPS), Fagron Sterile Services US, SCA Pharmaceuticals LLC, Leiters Health, Empower Pharmacy LLC, Wells Pharma of Houston LLC, Olympia Pharmaceuticals LLC, Belmar Pharma Solutions LLC, Pine Pharmaceuticals LLC, OSRX Inc., Medivant Healthcare, AnazaoHealth Corporation, Integration Medical (Integradose Compounding Services), Carie Boyd’s Prescription Shop, Exela Pharma Sciences LLC

Global 503B Outsourcing Facilities Market Trends and Insights

Major companies operating in the 503B outsourcing facilities market are focusing on expanding ready-to-administer sterile injectable portfolios to improve medication availability during shortages, streamline hospital pharmacy workflows, and support critical care treatment requirements. Ready-to-administer sterile injectable portfolios are standardized, pre-prepared sterile medications produced by 503B outsourcing facilities to improve medication safety, reduce preparation time, and ensure a reliable supply of compounded injectable drugs. For instance, in December 2024, Pine Pharmaceuticals, a US-based FDA-registered 503B outsourcing facility, announced the launch of norepinephrine 32 mg premix IV bags to expand its hospital-focused product offerings. The newly introduced product was designed to address the limited availability of specific norepinephrine concentrations while supporting customized patient care in healthcare facilities. The company further strengthened its portfolio of ready-to-administer sterile compounds, including critical care medications such as diltiazem HCl, epinephrine, and phenylephrine HCl, reinforcing its commitment to reducing nationwide drug shortages and supporting healthcare providers with cost-effective compounded solutions.

What Are Latest Mergers And Acquisitions In The 503B Outsourcing Facilities Market?

In September 2024, Hims & Hers Health, Inc., a US-based multi-specialty telehealth platform, acquired MedisourceRx for an undisclosed amount. With this acquisition, Hims & Hers aims to vertically integrate its supply chain and significantly enhance its domestic manufacturing capabilities for personalized, peptide-based medications to meet rising consumer demand. MedisourceRx is a US-based, FDA-registered 503B outsourcing facility that specializes in the production of sterile compounded medications.

Regional Outlook

North America was the largest region in the 503b outsourcing facilities market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the 503B Outsourcing Facilities Market?

The 503B outsourcing facilities market consists of revenues earned by entities by providing services such as customized medication preparation, batch manufacturing of compounded drugs, hospital pharmacy outsourcing, and ready-to-administer injectable preparation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the 503B Outsourcing Facilities Market Report 2026?

The 503B outsourcing facilities market research report is one of a series of new reports from The Business Research Company that provides 503B outsourcing facilities market statistics, including 503B outsourcing facilities industry global market size, regional shares, competitors with a 503B outsourcing facilities market share, detailed 503B outsourcing facilities market segments, market trends and opportunities, and any further data you may need to thrive in the 503B outsourcing facilities industry. This 503B outsourcing facilities market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.